Literature DB >> 10408363

Functional properties of soluble CD21.

V Frémeaux-Bacchi1, J P Kolb, S Rakotobé, M D Kazatchkine, E M Fischer.   

Abstract

Soluble receptors may display immunoregulatory properties by blocking interactions between ligands and their membrane receptors or by triggering specific biologic responses through interaction with counter part membrane receptors. A natural soluble form of CD21 that is cleaved from lymphocyte membrane CD21 circulates in normal human serum. Soluble CD21 retains the capacity to bind iC3b and CD23, the known ligands of membrane CD21. In a similar fashion to IgE complexes, another ligand of CD23, the soluble CD21 was shown to efficiently trigger CD23-signalling pathways in human monocytes. By inducing release of proinflammatory cytokines and upregulating expression of molecules involved in antigen presentation, soluble CD21 modulates critical monocyte functions that may be relevant to allergic and inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408363     DOI: 10.1016/s0162-3109(99)00026-0

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  6 in total

1.  Serum levels of soluble CD21 in patients with systemic sclerosis.

Authors:  Manabu Tomita; Takafumi Kadono; Norihito Yazawa; Tomohiko Kawashima; Zenshiro Tamaki; Ryuichi Ashida; Hanako Ohmatsu; Yoshihide Asano; Makoto Sugaya; Masahide Kubo; Hironobu Ihn; Kunihiko Tamaki; Shinichi Sato
Journal:  Rheumatol Int       Date:  2010-10-30       Impact factor: 2.631

2.  Soluble CD21 in sera and synovial fluid of arthritic patients.

Authors:  Thomas Grottenthaler; Johannes von Kempis; Sigune Goldacker; Harald Illges
Journal:  Rheumatol Int       Date:  2005-03-16       Impact factor: 2.631

3.  Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates.

Authors:  Hui Ding; Wolfgang M Prodinger; Jindrich Kopecek
Journal:  Biomacromolecules       Date:  2006-11       Impact factor: 6.988

Review 4.  Interactions between worm infections and malaria.

Authors:  Mathieu Nacher
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

5.  Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.

Authors:  Madhan Masilamani; Narendiran Rajasekaran; Anjana Singh; Hui-Zhi Low; Kerstin Albus; Swantje Anders; Frank Behne; Peter Eiermann; Katharina König; Clarissa Mindnich; Teodora Ribarska; Harald Illges
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

6.  B-cell activity in children with malaria.

Authors:  Jackson C Korir; Japhet K Magambo; Joseph K Mwatha; John N Waitumbi
Journal:  Malar J       Date:  2012-03-09       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.